Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
- Issued Date
- 2020
- Type
- Article
- Publisher
- BMC UROLOGY
- Language
- 영어
- ISSN
- 1471-2490
- Citation Volume
- 20
- Citation Number
- 1
- Citation Start Page
- 181
- Citation End Page
- 181
- Files in This Item:
-
-
There are no files associated with this item.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.